DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
MDX-1411
1
Antibody
Investigational
Unknown
Unknown
Lymphoma, Mantle-Cell
CD70 antigen cross-linking agent
MDX-1411
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PP-F11N LUTETIUM LU-177
1
Protein
Investigational
Unknown
Unknown
Thyroid Neoplasms
Unknown
PP-F11N LUTETIUM LU-177
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Protein
Molecular Formula:
C90H120LuN19O35
Molecular Weight:
2204.99
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
PHENSERINE, (+)-
1
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Unknown
PHENSERINE, (+)-
×
Maximum Phase:
1
First Approval:
None
UNII:
Z0O4TJ588O
Molecule Type:
Small molecule
Molecular Formula:
C20H23N3O2
Molecular Weight:
337.42
AlogP:
3.67
PSA:
44.81
HBD:
1.0
HBA:
#RotB:
2.0
Source:
MIK-BETA-1
1
Antibody
Investigational
Unknown
Unknown
Leukemia
Interleukin-2 receptor beta chain inhibitor
MIK-BETA-1
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MIV-818
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MIV-818
×
Maximum Phase:
1
First Approval:
None
UNII:
Q1I6YZ0NGF
Molecule Type:
Small molecule
Molecular Formula:
C22H30BrN4O8P
Molecular Weight:
589.38
AlogP:
3.37
PSA:
153.23
HBD:
2.0
HBA:
#RotB:
12.0
Source:
REBAUDIOSIDE A
1
Oligosaccharide
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
REBAUDIOSIDE A
×
Maximum Phase:
1
First Approval:
None
UNII:
B3FUD0528F
Molecule Type:
Oligosaccharide
Molecular Formula:
C44H70O23
Molecular Weight:
967.02
AlogP:
-5.11
PSA:
374.13
HBD:
14.0
HBA:
#RotB:
12.0
Source:
GSK-1614235
1
Unknown
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
GSK-1614235
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TALINOLOL
1
Small molecule
Investigational
Unknown
Unknown
Cardiovascular Diseases; Obesity, Morbid
Unknown
TALINOLOL
×
Maximum Phase:
1
First Approval:
None
UNII:
3S82268BKG
Molecule Type:
Small molecule
Molecular Formula:
C20H33N3O3
Molecular Weight:
363.5
AlogP:
3.27
PSA:
82.62
HBD:
4.0
HBA:
#RotB:
7.0
Source:
GALEGENIMAB
1
Antibody
Investigational
Unknown
Unknown
Macular Degeneration
Unknown
GALEGENIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ABBV-257
1
Unknown
Investigational
Unknown
Unknown
Arthritis, Rheumatoid
Unknown
ABBV-257
×
Maximum Phase:
1
First Approval:
None
UNII:
MA59O0RPES
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PP-F11N LUTETIUM
1
Protein
Investigational
Unknown
Unknown
Unknown
Unknown
PP-F11N LUTETIUM
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Protein
Molecular Formula:
C90H120LuN19O35
Molecular Weight:
2203.02
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ALOBRESIB
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Lymphoma; Prostatic Neoplasms, Castration-Resistant
Unknown
ALOBRESIB
×
Maximum Phase:
1
First Approval:
None
UNII:
3QBL0BLP3D
Molecule Type:
Small molecule
Molecular Formula:
C26H23N5O2
Molecular Weight:
437.5
AlogP:
4.79
PSA:
100.72
HBD:
2.0
HBA:
#RotB:
5.0
Source:
LY-2624587
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
LY-2624587
×
Maximum Phase:
1
First Approval:
None
UNII:
9T04Q997SD
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ELTANEXOR
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ELTANEXOR
×
Maximum Phase:
1
First Approval:
None
UNII:
Q59IQJ9NTK
Molecule Type:
Small molecule
Molecular Formula:
C17H10F6N6O
Molecular Weight:
428.3
AlogP:
3.26
PSA:
99.58
HBD:
1.0
HBA:
#RotB:
4.0
Source:
MDX-1342
1
Antibody
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Leukemia, Lymphocytic, Chronic, B-Cell
B-lymphocyte antigen CD19 binding agent
MDX-1342
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MCAF5352A
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
MCAF5352A
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
2'-F-ARA-DEOXYURIDINE
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
2'-F-ARA-DEOXYURIDINE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AXT914
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
AXT914
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HCBE-11
1
Antibody
Investigational
Unknown
Unknown
Neoplasms
Tumor necrosis factor receptor superfamily member 3 agonist
HCBE-11
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TUROFEXORATE ISOPROPYL
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Bile acid receptor FXR agonist
TUROFEXORATE ISOPROPYL
×
Maximum Phase:
1
First Approval:
None
UNII:
S6KDM312I5
Molecule Type:
Small molecule
Molecular Formula:
C25H24F2N2O3
Molecular Weight:
438.47
AlogP:
5.17
PSA:
62.4
HBD:
1.0
HBA:
#RotB:
3.0
Source:
BIO89-100
1
Unknown
Investigational
Unknown
Unknown
Hypertriglyceridemia; Non-alcoholic Fatty Liver Disease
Unknown
BIO89-100
×
Maximum Phase:
1
First Approval:
None
UNII:
UO870O6MFS
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MK-6592
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Serine/threonine-protein kinase Aurora inhibitor
MK-6592
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C25H26ClF2N7O2
Molecular Weight:
529.98
AlogP:
4.28
PSA:
99.27
HBD:
2.0
HBA:
#RotB:
7.0
Source:
OMIGAPIL
1
Small molecule
Investigational
Unknown
Unknown
Parkinson Disease; Amyotrophic Lateral Sclerosis
Unknown
OMIGAPIL
×
Maximum Phase:
1
First Approval:
None
UNII:
5V14HD0N4Q
Molecule Type:
Small molecule
Molecular Formula:
C19H17NO
Molecular Weight:
275.35
AlogP:
3.9
PSA:
12.47
HBD:
0.0
HBA:
#RotB:
3.0
Source:
LSZ102
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
LSZ102
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BUDIGALIMAB
1
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Colorectal Neoplasms; Head and Neck Neoplasms; HIV Infections; Neoplasms; Ovarian Neoplasms; Small Cell Lung Carcinoma
Programmed cell death protein 1 inhibitor
BUDIGALIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
6VDO4TY3OO
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NT-219
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
NT-219
×
Maximum Phase:
1
First Approval:
None
UNII:
K1WT1A1UP5
Molecule Type:
Small molecule
Molecular Formula:
C16H14BrNO5S
Molecular Weight:
412.26
AlogP:
3.11
PSA:
113.18
HBD:
6.0
HBA:
#RotB:
4.0
Source:
MCLA-158
1
Unknown
Investigational
Unknown
Unknown
Colorectal Neoplasms
Unknown
MCLA-158
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OXI-4503
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Neoplasms
Unknown
OXI-4503
×
Maximum Phase:
1
First Approval:
None
UNII:
JH6Z94GLUD
Molecule Type:
Small molecule
Molecular Formula:
C18H22O12P2
Molecular Weight:
492.31
AlogP:
2.83
PSA:
170.44
HBD:
4.0
HBA:
#RotB:
10.0
Source:
S-222611
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Epidermal growth factor receptor erbB1 inhibitor
S-222611
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BALAFILCON A
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BALAFILCON A
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PEN-866
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PEN-866
×
Maximum Phase:
1
First Approval:
None
UNII:
56DL1J49LR
Molecule Type:
Small molecule
Molecular Formula:
C49H49N7O9
Molecular Weight:
879.97
AlogP:
6.97
PSA:
207.03
HBD:
4.0
HBA:
#RotB:
9.0
Source:
SELITRECTINIB
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Neurotrophic tyrosine kinase receptor inhibitor
SELITRECTINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
0J45910S3X
Molecule Type:
Small molecule
Molecular Formula:
C20H21FN6O
Molecular Weight:
380.43
AlogP:
2.67
PSA:
75.42
HBD:
1.0
HBA:
#RotB:
0.0
Source:
MARZEPTACOG ALFA (ACTIVATED)
1
Unknown
Investigational
Unknown
Unknown
Hemophilia A
Unknown
MARZEPTACOG ALFA (ACTIVATED)
×
Maximum Phase:
1
First Approval:
None
UNII:
J5LT149M79
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ELUBRIXIN TOSYLATE
1
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive
Unknown
ELUBRIXIN TOSYLATE
×
Maximum Phase:
1
First Approval:
None
UNII:
13FVR7WD4P
Molecule Type:
Small molecule
Molecular Formula:
C24H25Cl2FN4O7S2
Molecular Weight:
635.52
AlogP:
3.08
PSA:
110.77
HBD:
4.0
HBA:
#RotB:
4.0
Source:
HYDROXYNORKETAMINE, (2R,6R)
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
HYDROXYNORKETAMINE, (2R,6R)
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C12H14ClNO2
Molecular Weight:
239.7
AlogP:
1.61
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
1.0
Source:
1
2
…
83
84
85
86
87
88
89
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA